Nicole Kuzmin-Nichols Selected Research

Disease Progression

6/2015	Humoral factors in ALS patients during disease progression.
1/2012	Multiple intravenous administrations of human umbilical cord blood cells benefit in a mouse model of ALS.
5/2010	Reduction of circulating endothelial cells in peripheral blood of ALS patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicole Kuzmin-Nichols Research Topics

Disease

8	Stroke (Strokes) 01/2016 - 04/2010
3	Disease Progression 06/2015 - 05/2010
2	Ischemia 01/2019 - 03/2010
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2016 - 01/2012
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2014 - 01/2012
2	Mucopolysaccharidosis III (Sanfilippo Syndrome) 01/2014 - 03/2006
2	Nervous System Diseases (Neurological Disorders) 05/2013 - 04/2010
2	Infarction (Infarctions) 05/2013 - 01/2011
2	Ischemic Stroke 06/2012 - 04/2010
1	Brain Ischemia (Cerebral Ischemia) 01/2019
1	Brain Injuries (Brain Injury) 01/2019
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2016
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 01/2016
1	Parkinson Disease (Parkinson's Disease) 01/2016
1	Type 2 Diabetes Mellitus (MODY) 09/2015
1	Diabetes Mellitus 10/2014
1	Amyloid Plaque 02/2013
1	Cognitive Dysfunction 02/2013
1	Gliosis 02/2013
1	Amyloidosis 02/2013
1	Basal Ganglia Diseases (Basal Ganglia Disease) 01/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2003

Drug/Important Bio-Agent (IBA)

2	alpha-N-acetyl-D-glucosaminidase (alpha-N-acetylglucosaminidase)IBA 01/2014 - 03/2006
2	EnzymesIBA 01/2014 - 03/2006
2	Nerve Growth Factors (Neurotrophins)IBA 05/2013 - 01/2011
1	CytokinesIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Immunologic Factors (Immunomodulators)IBA 01/2016
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2015
1	AntioxidantsIBA 06/2015
1	Biomarkers (Surrogate Marker)IBA 06/2015
1	Angiopoietin-1IBA 10/2014
1	Phosphates (Orthophosphate)IBA 10/2014
1	SilverIBA 10/2014
1	Luxol Fast Blue MBS (Luxol fast blue)IBA 10/2014
1	Acetylglucosaminidase (NAGase)IBA 01/2014
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2014
1	Neuroprotective AgentsIBA 05/2013
1	Presenilin-1IBA 02/2013
1	Amyloid (Amyloid Fibrils)IBA 02/2013
1	Fibrinolysin FDA Link 06/2012
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2012
1	Simvastatin (Zocor)FDA LinkGeneric 01/2012
1	Indicators and Reagents (Reagents)IBA 05/2010
1	Glucose (Dextrose)FDA LinkGeneric 04/2010
1	Oxygen (Dioxygen)IBA 04/2010

Therapy/Procedure

11	Therapeutics 01/2019 - 01/2003
5	Transplantation 05/2013 - 03/2010
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2012 - 04/2010
1	Immunomodulation 01/2019